About Us

Corporate Overview

Platform Stem Cell Technology
Tissue Repair Cell (TRC) technology
Over 250 Patients Treated to Date
Active Clinical Trial Program
Comprehensive Patent Portfolio
U.S. Patents – 26 issued, 4 pending
Foreign Patents – 41 issued, 4 pending
Headquarters – Ann Arbor, Michigan
70 Employees – 14 PhDs and 3 MDs